LAVANNYA PANDIT to Adult
This is a "connection" page, showing publications LAVANNYA PANDIT has written about Adult.
Connection Strength
0.073
-
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Lancet Infect Dis. 2022 05; 22(5):622-635.
Score: 0.031
-
Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231200386.
Score: 0.008
-
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. Ann Intern Med. 2022 10; 175(10):1401-1410.
Score: 0.008
-
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. N Engl J Med. 2021 03 11; 384(10):905-914.
Score: 0.007
-
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 01 07; 384(1):20-30.
Score: 0.007
-
Extracellular Vesicles Attenuate Nitrofen-Mediated Human Pulmonary Artery Endothelial Dysfunction: Implications for Congenital Diaphragmatic Hernia. Stem Cells Dev. 2020 08 01; 29(15):967-980.
Score: 0.007
-
Regulation of IL-4 receptor signaling by STUB1 in lung inflammation. Am J Respir Crit Care Med. 2014 Jan 01; 189(1):16-29.
Score: 0.004